湖南宇晶机器股份有限公司 第五届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码:002943 证券简称:宇晶股份 公告编号：2025-054 三、备查文件 1、第五届董事会第八次会议决议； 2、第五届董事会审计委员会第五次会议决议。 特此公告。 湖南宇晶机器股份有限公司 董事会 一、董事会会议召开情况 湖南宇晶机器股份有限公司（以下简称"公司"）第五届董事会第八次 会议通知于 2025 年 10 月 14 日以电话及电子邮件方式等方式发出，会议于 2025 年 10 月 24 日在公司一楼会议室以现场和通讯方式召开。本次会议由 董事长杨宇红先生主持，本次会议应参会董事 7 名，实际参会董事 7 名，其 中公司董事杨佳葳先生、职工董事邓湘浩先生和独立董事唐曦先生以通讯方 式参会，公司高级管理人员列席了会议。本次会议的召集、召开及表决程序 符合《公司法》等有关法律、法规、规章和《公司章程》的规定。 二、董事会会议审议情况 1、审议通过了《关于 2025 年第三季度报告的议案》。 公司董事会审计委员会审议通过了该议案，具体内容详见 ...

湖南宇晶机器股份有限公司 2025 年第三季度报告 证券代码：002943 证券简称：宇晶股份 公告编号：2025-053 湖南宇晶机器股份有限公司 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗 漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真 实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 湖南宇晶机器股份有限公司 2025 年第三季度报告 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述 或重大遗漏。 一、主要财务数据 （一） 主要会计数据和财务指标 | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益（包括已计提 | -261,485.45 | -246,640.14 | | | 资产减值准备的冲销部分） | | | | | 计入当期损益的政府补助（与公司正 常经营业务密切相关、符合 ...

长沙晚报掌上长沙10月19日讯（全媒体记者 刘军）截至19日，A股市场稀土永磁板块上已有8家公司发 布三季报预告且全部预喜，多家公司前三季度净利润增幅在100%以上。记者发现，该板块上有3只湘 股，虽然目前都没有发布三季报预告，但3只个股的股价今年以来都已经大涨。 发布了三季报业绩预告的8只个股分别为中科三环、盛和资源、北方稀土、广晟有色、领益智造、横店 东磁、金力永磁、有研新材。 北方稀土预计今年前三季度实现净利润15.1亿元到15.7亿元，同比增长272.54%到287.34%。公司全力保 障原料产品供应，以市场需求为导向，深化营销模式创新，强化营销运作，多措并举积极消化库存，冶 炼分离、稀土金属、稀土功能材料、永磁电机等主要产品产销量同比实现不同幅度增长。 中科三环预计今年前三季度净利润为8000万元—1亿元，同比增长290.24%～337.79%。公司采取稳中求 进、以进促稳的经营方针，积极应对各类突发事件和风险，持续开展技术创新和管理优化，采取降本增 效、降费增率等有效措施，努力开拓市场。通过全体员工的共同努力，公司经营业绩同比取得了较大幅 度的增长。 盛和资源预计今年前三季度实现归属于上市公司股东 ...

湖南宇晶机器股份有限公司 关于控股股东、实际控制人及高级管理人员减持计划 实施完成的公告 公司控股股东、实际控制人、董事长杨宇红先生和高级管理人员周波评先生保证向 本公司提供的信息真实、准确和完整，没有虚假记载，误导性陈述或者重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 湖南宇晶机器股份有限公司（以下简称"公司"）于 2025 年 7 月 12 日披露了 《关于控股股东、实际控制人减持计划的预披露公告》（公告编号：2025-031）。 公司控股股东、实际控制人、董事长杨宇红先生计划在该公告披露日起 15 个交易 日后的 3 个月内以集中竞价或大宗交易方式减持本公司股份不超过 6,105,000 股， 占公司总股本比例的 2.9722%，占剔除公司回购专用证券账户股份后总股本比例的 2.9956%。其中，采取集中竞价交易方式减持的，在连续 90 个自然日内，减持股份 总数不超过公司股份总数的 1%；通过大宗交易减持的，在连续 90 个自然日内，减 持股份的总数不超过公司股份总数的 2%。 证券代码：002943 证券简称：宇晶股份 公告编号：2025-052 公司于 2025 ...

Core Insights - The superhard materials industry is transitioning from a niche market to a strategic necessity, driven by demand in photovoltaic, semiconductor, and high-end manufacturing sectors [1][3] - The article analyzes the profitability of 27 companies in the superhard materials sector, focusing on 10 core companies based on their comprehensive profitability [1][4] Industry Dynamics - Superhard materials, including synthetic diamonds and cubic boron nitride (CBN), are essential for supporting key industries such as photovoltaics, semiconductors, and advanced manufacturing [3] - Three main demand drivers are identified: - Photovoltaics: Increased demand for diamond wire saws due to larger silicon wafer sizes and thinner wafers [3] - Semiconductors: Diamond substrates are seen as critical materials for the post-silicon era, with potential market sizes reaching hundreds of billions [3] - High-end manufacturing: Demand for precision tools and wear-resistant components is growing, with superhard materials offering significantly longer lifespans compared to traditional tools [3] Company Analysis - **Zhongtung High-tech (000657.SZ)**: Leading in hard alloy tools with a stable ROE of 12.53% and a gross margin of 22.07%, benefiting from a comprehensive industry chain and high technical barriers [4][5] - **Guojijiang Precision (002046.SZ)**: Dual-driven by superhard materials and equipment, with a gross margin of 35.27% and a rising ROE of 8.31% [5][6] - **Xinxin Co., Ltd. (688257.SH)**: Global presence with over 40% of revenue from overseas, showing a gross margin of 31.81% and a ROE of 8.40% [6][7] - **World (688028.SH)**: High-end tool manufacturer with a gross margin of 46.10% and a strong market position in diamond tools [7][8] - **Meichang Co., Ltd. (300861.SZ)**: Dominates the diamond wire market with over 60% market share, benefiting from the photovoltaic sector's growth [8][9] - **Zhongbing Hongjian (000519.SZ)**: Military and superhard materials dual business model, with significant potential for growth as demand increases [9][10] - **Oke Yi (688308.SH)**: Focused on CNC tools with a gross margin of 22.66%, benefiting from strong customer relationships [10] - **Tongyu Heavy Industry (300185.SZ)**: Wind power components and hard alloy business, with a gross margin of 12.73% [10] - **Fuliwang (688678.SH)**: Cross-industry growth with a focus on precision components and diamond wire, showing a gross margin of 24.41% [10] - **Yujing Co., Ltd. (002943.SZ)**: Potential in diamond wire products, with a focus on synergy between equipment and materials [10]

Group 1 - Six stocks received buy ratings from institutions today, with Baijia Shenzhou-U, Gongchuang Turf, and Yujing Co. being newly covered by institutions [1][2] - Among the buy ratings, three were first-time ratings for Baijia Shenzhou-U and Gongchuang Turf [1] - The average decline for stocks with buy ratings today was 1.91%, underperforming the Shanghai Composite Index, with notable declines in SMIC, Baijia Shenzhou-U, and Yujing Co. at 7.89%, 6.20%, and 1.15% respectively [1] Group 2 - The latest buy ratings include SMIC with a target price of 238.00 yuan and a closing price of 127.95 yuan, and Gongchuang Turf with a closing price of 31.20 yuan [2] - Other stocks rated include Aorijun with a target price of 6.76 yuan and a closing price of 5.69 yuan, and Yujing Co. with a target price of 36.10 yuan [2] - Baijia Shenzhou-U received a strong recommendation with a closing price of 285.59 yuan, but no target price was provided [2]

Core Viewpoint - The major shareholder, Hangzhou Queishi Private Fund Management Co., Ltd. - Queishi Quanli No. 1 Private Securities Investment Fund, plans to reduce its stake in Hunan Yujing Machinery Co., Ltd. by up to 4,280,000 shares over a three-month period starting from October 27, 2025, due to personal funding needs [3][6][10]. Group 1: Shareholder Information - The total share capital of Hunan Yujing Machinery Co., Ltd. is 205,458,161 shares, with 203,857,501 shares after excluding shares in the company's repurchase account [3][5]. - The shareholder, Queishi Quanli No. 1, holds 14,300,000 shares, representing 6.9601% of the total share capital and 7.0147% of the adjusted total [5][6]. Group 2: Reduction Plan Details - The planned reduction will occur through centralized bidding or block trading, with a maximum of 4,280,000 shares, accounting for 2.0831% of the total share capital [7][9]. - The reduction period is set from October 27, 2025, to January 26, 2026, with the price determined by market conditions at the time of sale [10][11]. - The shareholder's previous intentions and commitments regarding shareholding remain consistent with this reduction plan [11].

Core Points - Yu Jing Co., Ltd. announced its total share capital as of the announcement date is 205,458,161 shares, with 203,857,501 shares after excluding shares held in the company's repurchase account [1] - Hangzhou Que Shi Private Fund Management Co., Ltd. plans to reduce its holdings of 14,300,000 shares, representing 6.9601% of the total share capital, within three months starting from October 27, 2025, to January 26, 2026 [1] - The planned reduction will not exceed 4,280,000 shares, which is 2.0831% of the total share capital, and specific limits are set for both centralized bidding and block trading methods [1] Summary by Category Share Capital - The total share capital of Yu Jing Co., Ltd. is 205,458,161 shares, and the adjusted total after excluding repurchased shares is 203,857,501 shares [1] Shareholder Actions - Hangzhou Que Shi Private Fund Management Co., Ltd. holds 14,300,000 shares, which is 6.9601% of the total share capital and 7.0147% of the adjusted total [1] - The fund plans to reduce its holdings by up to 4,280,000 shares over a three-month period starting from October 27, 2025 [1] Trading Methods and Limits - The reduction will be executed through centralized bidding or block trading, with specific limits: no more than 1% of total shares can be sold in any 90-day period via centralized bidding, and no more than 2% via block trading [1]

Group 1 - Donghua Energy's Masen increased its stake by 0.34% [1] - Guoxin Technology's shareholders plan to reduce their holdings by up to 4.5% [1] - Guoguang Electric's shareholders, including Guozhiguang and Tianyi Venture Capital, intend to reduce their holdings by up to 3.85% [1] Group 2 - Xincheng Technology's four shareholders plan to reduce their holdings by 2.0316% in March [1] - Yujing Co., Ltd.'s shareholder Que Shiquan Li No. 1 intends to reduce its holdings by no more than 4.28 million shares [1] - Huiyu Pharmaceutical's Wang Xiaopeng plans to reduce his holdings by 3% over three months [1] Group 3 - Huaxi Securities' Jianan Spring Company plans to reduce its holdings by 1% within three months [1] - Beimo Gaoke's Chen Jianfeng intends to reduce his holdings by 2.49% [1] - Maiqu'er's shareholders plan to reduce their total shareholding by no more than 2% [1] Group 4 - Huadong Heavy Machinery's Tianchen Jinting No. 1 intends to reduce its holdings by 1.00% [1] - Cangge Mining's Xinsha Hongyun Investment plans to reduce its holdings by 0.60% [1] - Shengke Communication's major fund's shareholding ratio has decreased to 15% [1]

Group 1 - Shanghai Zhiyuan Hengyue plans to acquire 37% of the shares of Shangwei New Materials at a price of 7.78 yuan per share, requiring a maximum total funding of 1.16 billion yuan [1] - The acquisition period is set for 30 calendar days, from September 29, 2025, to October 28, 2025 [1] - Zhiyuan Hengyue and Zhiyuan Xinchuan intend to acquire at least 63.62% and up to 66.99% of Shangwei New Materials' shares [2] Group 2 - Heng Rui Pharmaceutical has signed a licensing agreement for the innovative drug SHRA1811, receiving an upfront payment of 18 million dollars and is eligible for up to 1.093 billion dollars in milestone payments [3] - The agreement aims to expand the overseas market for SHRA1811 and enhance the company's innovative brand and overseas performance [3] Group 3 - Tian Shili's subsidiary has received approval for clinical trials of TSL2109 capsules, a dual-target small molecule inhibitor for advanced solid tumors, with no similar drugs currently in clinical trials [4] - The cumulative R&D investment in TSL2109 capsules by Jiangsu Diyi has reached 24.6251 million yuan [4] Group 4 - Wanhui High-tech expects a net profit of 340 million to 420 million yuan for the first three quarters, representing a year-on-year growth of 69.81% to 109.77% [5]